A dominant negative mutant of the KCC1 K-Cl cotransporter: Both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity

Sabina Casula, Boris E. Shmukler, Sabine Wilhelm, Alan K. Stuart-Tilley, Wanfang Su, Marina N. Chernova, Carlo Brugnara, Seth L. Alper

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

K-Cl cotransport regulates cell volume and chloride equilibrium potential. Inhibition of erythroid K-Cl co-transport has emerged as an important adjunct strategy for the treatment of sickle cell anemia. However, structure-function relationships among the polypeptide products of the four K-Cl cotransporter (KCC) genes are little understood. We have investigated the importance of the N- and C-terminal cytoplasmic domains of mouse KCC1 to its K-Cl cotransport function expressed in Xenopus oocytes. Truncation of as few as eight C-terminal amino acids (aa) abolished function despite continued polypeptide accumulation and surface expression. These C-terminal loss-of-function mutants lacked a dominant negative phenotype. Truncation of the N-terminal 46 aa diminished function. Removal of 89 or 117 aa (ΔN117) abolished function despite continued polypeptide accumulation and surface expression and exhibited dominant negative phenotypes that required the presence of the C-terminal cytoplasmic domain. The dominant negative loss-of-function mutant Δ N117 was co-immunoprecipitated with wild type KCC1 polypeptide, and its co-expression did not reduce wild type KCC1 at the oocyte surface. ΔN117 also exhibited dominant negative inhibition of human KCC1 and KCC3 and, with lower potency, mouse KCC4 and rat KCC2.

Original languageEnglish
Pages (from-to)41870-41878
Number of pages9
JournalJournal of Biological Chemistry
Volume276
Issue number45
DOIs
StatePublished - Nov 9 2001
Externally publishedYes

Fingerprint

Peptides
Amino Acids
Oocytes
Phenotype
Sickle Cell Anemia
Xenopus
Cell Size
Chlorides
potassium-chloride symporters
Rats
Genes

ASJC Scopus subject areas

  • Biochemistry

Cite this

A dominant negative mutant of the KCC1 K-Cl cotransporter : Both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity. / Casula, Sabina; Shmukler, Boris E.; Wilhelm, Sabine; Stuart-Tilley, Alan K.; Su, Wanfang; Chernova, Marina N.; Brugnara, Carlo; Alper, Seth L.

In: Journal of Biological Chemistry, Vol. 276, No. 45, 09.11.2001, p. 41870-41878.

Research output: Contribution to journalArticle

Casula, S, Shmukler, BE, Wilhelm, S, Stuart-Tilley, AK, Su, W, Chernova, MN, Brugnara, C & Alper, SL 2001, 'A dominant negative mutant of the KCC1 K-Cl cotransporter: Both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity', Journal of Biological Chemistry, vol. 276, no. 45, pp. 41870-41878. https://doi.org/10.1074/jbc.M107155200
Casula, Sabina ; Shmukler, Boris E. ; Wilhelm, Sabine ; Stuart-Tilley, Alan K. ; Su, Wanfang ; Chernova, Marina N. ; Brugnara, Carlo ; Alper, Seth L. / A dominant negative mutant of the KCC1 K-Cl cotransporter : Both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 45. pp. 41870-41878.
@article{1dd2c8e636eb43b98100ce62eb771dda,
title = "A dominant negative mutant of the KCC1 K-Cl cotransporter: Both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity",
abstract = "K-Cl cotransport regulates cell volume and chloride equilibrium potential. Inhibition of erythroid K-Cl co-transport has emerged as an important adjunct strategy for the treatment of sickle cell anemia. However, structure-function relationships among the polypeptide products of the four K-Cl cotransporter (KCC) genes are little understood. We have investigated the importance of the N- and C-terminal cytoplasmic domains of mouse KCC1 to its K-Cl cotransport function expressed in Xenopus oocytes. Truncation of as few as eight C-terminal amino acids (aa) abolished function despite continued polypeptide accumulation and surface expression. These C-terminal loss-of-function mutants lacked a dominant negative phenotype. Truncation of the N-terminal 46 aa diminished function. Removal of 89 or 117 aa (ΔN117) abolished function despite continued polypeptide accumulation and surface expression and exhibited dominant negative phenotypes that required the presence of the C-terminal cytoplasmic domain. The dominant negative loss-of-function mutant Δ N117 was co-immunoprecipitated with wild type KCC1 polypeptide, and its co-expression did not reduce wild type KCC1 at the oocyte surface. ΔN117 also exhibited dominant negative inhibition of human KCC1 and KCC3 and, with lower potency, mouse KCC4 and rat KCC2.",
author = "Sabina Casula and Shmukler, {Boris E.} and Sabine Wilhelm and Stuart-Tilley, {Alan K.} and Wanfang Su and Chernova, {Marina N.} and Carlo Brugnara and Alper, {Seth L.}",
year = "2001",
month = "11",
day = "9",
doi = "10.1074/jbc.M107155200",
language = "English",
volume = "276",
pages = "41870--41878",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "45",

}

TY - JOUR

T1 - A dominant negative mutant of the KCC1 K-Cl cotransporter

T2 - Both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity

AU - Casula, Sabina

AU - Shmukler, Boris E.

AU - Wilhelm, Sabine

AU - Stuart-Tilley, Alan K.

AU - Su, Wanfang

AU - Chernova, Marina N.

AU - Brugnara, Carlo

AU - Alper, Seth L.

PY - 2001/11/9

Y1 - 2001/11/9

N2 - K-Cl cotransport regulates cell volume and chloride equilibrium potential. Inhibition of erythroid K-Cl co-transport has emerged as an important adjunct strategy for the treatment of sickle cell anemia. However, structure-function relationships among the polypeptide products of the four K-Cl cotransporter (KCC) genes are little understood. We have investigated the importance of the N- and C-terminal cytoplasmic domains of mouse KCC1 to its K-Cl cotransport function expressed in Xenopus oocytes. Truncation of as few as eight C-terminal amino acids (aa) abolished function despite continued polypeptide accumulation and surface expression. These C-terminal loss-of-function mutants lacked a dominant negative phenotype. Truncation of the N-terminal 46 aa diminished function. Removal of 89 or 117 aa (ΔN117) abolished function despite continued polypeptide accumulation and surface expression and exhibited dominant negative phenotypes that required the presence of the C-terminal cytoplasmic domain. The dominant negative loss-of-function mutant Δ N117 was co-immunoprecipitated with wild type KCC1 polypeptide, and its co-expression did not reduce wild type KCC1 at the oocyte surface. ΔN117 also exhibited dominant negative inhibition of human KCC1 and KCC3 and, with lower potency, mouse KCC4 and rat KCC2.

AB - K-Cl cotransport regulates cell volume and chloride equilibrium potential. Inhibition of erythroid K-Cl co-transport has emerged as an important adjunct strategy for the treatment of sickle cell anemia. However, structure-function relationships among the polypeptide products of the four K-Cl cotransporter (KCC) genes are little understood. We have investigated the importance of the N- and C-terminal cytoplasmic domains of mouse KCC1 to its K-Cl cotransport function expressed in Xenopus oocytes. Truncation of as few as eight C-terminal amino acids (aa) abolished function despite continued polypeptide accumulation and surface expression. These C-terminal loss-of-function mutants lacked a dominant negative phenotype. Truncation of the N-terminal 46 aa diminished function. Removal of 89 or 117 aa (ΔN117) abolished function despite continued polypeptide accumulation and surface expression and exhibited dominant negative phenotypes that required the presence of the C-terminal cytoplasmic domain. The dominant negative loss-of-function mutant Δ N117 was co-immunoprecipitated with wild type KCC1 polypeptide, and its co-expression did not reduce wild type KCC1 at the oocyte surface. ΔN117 also exhibited dominant negative inhibition of human KCC1 and KCC3 and, with lower potency, mouse KCC4 and rat KCC2.

UR - http://www.scopus.com/inward/record.url?scp=0035834753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035834753&partnerID=8YFLogxK

U2 - 10.1074/jbc.M107155200

DO - 10.1074/jbc.M107155200

M3 - Article

C2 - 11551954

AN - SCOPUS:0035834753

VL - 276

SP - 41870

EP - 41878

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 45

ER -